
Establishment Labs Holdings ESTA
$ 64.86
-3.93%
Quarterly report 2025-Q3
added 11-07-2025
Establishment Labs Holdings Interest Expense 2011-2026 | ESTA
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Establishment Labs Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.3 M | 816 K | -3.18 M | 9.06 M | 9.37 M | 8.7 M | 8.81 M | 10.4 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.4 M | -15.3 M | 3.59 M |
Quarterly Interest Expense Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -542 K | 4.38 M | 2.75 M | - | 2.05 M | -2.78 M | -3.04 M | - | 3.68 M | 3.62 M | 3.76 M | - | 3.88 M | 3.39 M | 2.29 M | - | 2.29 M | 2.25 M | 2.2 M | - | 2.89 M | 2.13 M | 2.15 M | - | 1.8 M | 2.52 M | 2.24 M | - | 2.2 M | 2.17 M | 2.17 M | - | 6.69 M | 1.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.69 M | -3.04 M | 2.24 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
AxoGen
AXGN
|
-199 K | $ 31.85 | 2.68 % | $ 1.41 B | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.97 | -1.59 % | $ 644 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.89 | -2.51 % | $ 135 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 16.95 | -4.48 % | $ 2.42 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 312.8 | -0.23 % | $ 8.83 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 41.19 | -0.91 % | $ 1.27 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.69 | -9.12 % | $ 138 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 50.26 | 3.85 % | $ 7.49 K | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 91.09 | 3.43 % | $ 134 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 121.01 | -0.61 % | $ 211 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
78 K | $ 27.84 | 0.04 % | $ 235 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.75 | -3.35 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.81 | -3.78 % | $ 83.2 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.82 | -5.67 % | $ 374 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.68 | 0.24 % | $ 122 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 102.68 | 0.67 % | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
-3.52 M | $ 84.87 | -1.06 % | $ 2.85 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.45 | 0.55 % | $ 3.39 B | ||
|
Globus Medical
GMED
|
2.2 M | $ 92.68 | -0.85 % | $ 12.6 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 11.98 | -3.51 % | $ 923 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 1.78 | 0.28 % | $ 69.6 M |